Analyst Ratings for Repligen Corp. (RGEN)Updated: 2017-07-27
Shares of Repligen Corp. (NASDAQ:RGEN) have received a consensus rating of Overweight from Wall Street analysts. RGEN had previously received a consensus rating of Overweight a month ago.
A buy rating was issued by 4 analysts, 0 issued an overweight rating, 2 issued a hold rating, 0 issued an underweight rating, and 0 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 1. Over the same time period, there has been an increase of 0 in the number of analysts with a negative outlook on the stock.
Several price targets were given for RGEN by the analysts covering the stock. The highest price target was 50, which equates to a potential upside of 22.79 percent. The lowest price target was 40, implying a possible loss of -1.77 percent. It is crucial to not blindly accept any price targets or stock ratings, because many analysts have it in their best interest to give positive coverage of certain stocks.
Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of 0 percent. This can be compared with the average change in earnings estimates over the past 3 months, which is -11.76 percent. Meanwhile, fiscal year estimates have been revised upwards by 0 percent, compared to last month. If we look at the last 90 days instead, we find a net average change of 1.82 percent in FY estimates.
Another thing investors often look at is the level of agreement among analysts' revisions. 0 analysts made positive revisions to their quarterly estimates over the past month, while 0 analysts revised their estimates downwards. Over the same time period, 0 analysts revised their FY earnings estimates upwards, while 2 analysts made negative revisions to their fiscal year's estimates.
RGEN has an estimated earnings growth rate of 43.7 percent as forecasted by analysts. Another measure frequently examined by investors is the PEG ratio. A lower PEG ratio is favorable, as that can indicate whether the high price level of a stock is warranted by high growth. Many investors consider PEG ratios between 0 and 1 as preferrable, though it could be better to see where the ratio stands relative to peers in the industry. The PEG ratio of RGEN is 2.45.
RGEN has traded between a high of 46.81 and a low of 26.16 over the past year. The current market price is above the trailing year's low by 55.66 percent, and 13.01 percent lower than its 52-week high. RGEN has a price/earnings ratio of 107.16. Investors typically compare the P/E ratio to a company's peers in the industry. The RGEN value stock report compares RGEN to some of its peers using value stock charts. The stock has a market capitalization of $1.54 billion. RGEN is estimated to release their earnings results for the quarter on 0000-00-00, days from today.